Bicycle Therapeutics plc (NASDAQ: BCYC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BICYCLE THERAPEUTICS PLC

Bicycle Therapeutics plc (NASDAQ: BCYC)
Listen to this Section


$4.11
-0.1650 ( -3.86% ) 282.3K

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Market Data


Open $4.11
Previous Close $4.27
Volume 282.3K
Market Cap $293.21M
Day Range $4.10 - $4.41
52 Week Range $4.10 - $9.36
Shares Outstanding 69.81M
Change % -3.86%
Net Change ▼ -0.1650
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,025,887.00

Date Type Amount Purchased Purchaser
2024-12-17 Buy 2809.00 BAKER BROS. ADVISORS LP
2024-07-08 Sale -246.00 Hannay Michael Charles Ferguson
2024-07-08 Sale -779.00 Keen Nicholas
2024-07-08 Sale -3194.00 Lee Kevin
2024-07-08 Sale -967.00 Crockett Nigel
2024-07-08 Sale -967.00 Skynner Michael
2024-07-08 Sale -967.00 Milnes Alistair
2024-07-08 Sale -148.00 Thompson Travis Alvin
2024-06-20 Sale -196098.00 BAKER BROS. ADVISORS LP
2024-05-29 Sale -1429986.00 BAKER BROS. ADVISORS LP

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Oct 30, 2025
10-q Quarterly Reports 77 Oct 30, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Sep 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy